Schafer Cullen Capital Management Trimmed Astrazeneca Plc (Adr) (AZN) Position; Castlight Health (CSLT) Had 5 Bullish Analysts

July 13, 2017 - By Linda Rogers

Among 13 analysts covering Castlight Health (NYSE:CSLT), 5 have Buy rating, 1 Sell and 7 Hold. Therefore 38% are positive. Castlight Health had 21 analyst reports since October 9, 2015 according to SRatingsIntel. Canaccord Genuity maintained the stock with “Hold” rating in Friday, June 30 report. The stock of Castlight Health Inc (NYSE:CSLT) has “Mkt Perform” rating given on Wednesday, November 18 by FBR Capital. FBR Capital maintained it with “Mkt Perform” rating and $4 target in Wednesday, May 11 report. The stock of Castlight Health Inc (NYSE:CSLT) has “Mkt Perform” rating given on Thursday, January 5 by Raymond James. The stock of Castlight Health Inc (NYSE:CSLT) has “Mkt Perform” rating given on Thursday, November 5 by Leerink Swann. Stifel Nicolaus maintained it with “Buy” rating and $500 target in Monday, July 10 report. The rating was downgraded by Morgan Stanley on Friday, May 12 to “Underweight”. The stock has “Overweight” rating by First Analysis on Friday, October 9. Topeka Capital Markets maintained Castlight Health Inc (NYSE:CSLT) rating on Thursday, February 18. Topeka Capital Markets has “Buy” rating and $6 target. The stock of Castlight Health Inc (NYSE:CSLT) earned “Buy” rating by Stifel Nicolaus on Thursday, February 18. See Castlight Health Inc (NYSE:CSLT) latest ratings:

10/07/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $5.0000 Maintain
30/06/2017 Broker: Canaccord Genuity Rating: Hold New Target: $5.0000 Maintain
06/06/2017 Broker: Chardan Capital Markets Rating: Buy New Target: $4.5 Initiates Coverage On
15/05/2017 Broker: Morgan Stanley Old Rating: Equal Weight New Rating: Underperform Old Target: $4.00 New Target: $3.75 Downgrade
12/05/2017 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Underweight Downgrade
10/05/2017 Broker: Dougherty & Company Rating: Buy New Target: $5.50 Initiate
30/01/2017 Broker: Cowen & Co Rating: Market Perform New Target: $4.00 Initiates Coverage On

Schafer Cullen Capital Management Inc decreased Astrazeneca Plc (Adr) (AZN) stake by 13.87% reported in 2016Q4 SEC filing. Schafer Cullen Capital Management Inc sold 587,442 shares as Astrazeneca Plc (Adr) (AZN)’s stock rose 16.26%. The Schafer Cullen Capital Management Inc holds 3.65M shares with $99.65M value, down from 4.23 million last quarter. Astrazeneca Plc (Adr) now has $84.09 billion valuation. The stock rose 0.59% or $0.2 reaching $33.12. About 11.03M shares traded or 191.03% up from the average. AstraZeneca plc (ADR) (NYSE:AZN) has risen 19.45% since July 13, 2016 and is uptrending. It has outperformed by 2.75% the S&P500.

Schafer Cullen Capital Management Inc increased Mobile Telesystems Pjsc (Adr) (NYSE:MBT) stake by 51,519 shares to 494,834 valued at $4.51 million in 2016Q4. It also upped Zurich Insurance Group Ltd. (A (ZURVY) stake by 848,745 shares and now owns 2.38 million shares. Vina Concha Y Toro Sa (Adr) (NYSE:VCO) was raised too.

Among 19 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. AstraZeneca plc (ADR) had 26 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Friday, February 26. As per Monday, August 29, the company rating was upgraded by Argus Research. The stock of AstraZeneca plc (ADR) (NYSE:AZN) has “Overweight” rating given on Tuesday, December 1 by Morgan Stanley. The rating was maintained by Leerink Swann with “Market Perform” on Monday, May 2. The stock of AstraZeneca plc (ADR) (NYSE:AZN) has “Buy” rating given on Friday, July 31 by S&P Research. The stock of AstraZeneca plc (ADR) (NYSE:AZN) earned “Equal-Weight” rating by Barclays Capital on Tuesday, January 19. The stock of AstraZeneca plc (ADR) (NYSE:AZN) earned “Buy” rating by HSBC on Wednesday, September 2. On Monday, September 14 the stock rating was upgraded by Deutsche Bank to “Buy”. The company was initiated on Friday, September 23 by Piperjaffray. UBS downgraded AstraZeneca plc (ADR) (NYSE:AZN) on Wednesday, April 5 to “Neutral” rating.

Analysts await AstraZeneca plc (ADR) (NYSE:AZN) to report earnings on July, 27. They expect $0.44 earnings per share, down 46.99% or $0.39 from last year’s $0.83 per share. AZN’s profit will be $1.12 billion for 18.82 P/E if the $0.44 EPS becomes a reality. After $0.99 actual earnings per share reported by AstraZeneca plc (ADR) for the previous quarter, Wall Street now forecasts -55.56% negative EPS growth.

About 258,278 shares traded. Castlight Health Inc (NYSE:CSLT) has declined 18.00% since July 13, 2016 and is downtrending. It has underperformed by 34.70% the S&P500.

Investors sentiment decreased to 1.37 in 2016 Q4. Its down 0.32, from 1.69 in 2016Q3. It fall, as 11 investors sold Castlight Health Inc shares while 24 reduced holdings. 18 funds opened positions while 30 raised stakes. 40.49 million shares or 1.13% more from 40.04 million shares in 2016Q3 were reported. Rhumbline Advisers has invested 0% in Castlight Health Inc (NYSE:CSLT). Blackrock Fund Advsrs stated it has 1.31M shares. Prudential Public Limited Company stated it has 1.62M shares. Blackrock Limited stated it has 0% in Castlight Health Inc (NYSE:CSLT). Redmile Ltd invested in 10,229 shares. Raymond James & Associate stated it has 86,800 shares. New York State Common Retirement Fund has 0% invested in Castlight Health Inc (NYSE:CSLT) for 30,900 shares. Awm Inv Co has invested 0.48% in Castlight Health Inc (NYSE:CSLT). Blackrock Institutional Trust Na holds 0% in Castlight Health Inc (NYSE:CSLT) or 962,953 shares. Moreover, Northern has 0% invested in Castlight Health Inc (NYSE:CSLT). Sfmg Limited Liability reported 10,000 shares. Maverick Capital Limited holds 0.08% or 1.19 million shares. Verition Fund Mgmt Ltd Liability Company reported 70,000 shares stake. Eventide Asset Limited Com invested 0.38% of its portfolio in Castlight Health Inc (NYSE:CSLT). Manufacturers Life Communications The stated it has 32,303 shares or 0% of all its holdings.

Castlight Health, Inc. offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The company has market cap of $587.09 million. The Firm operates through cloud products segment. It currently has negative earnings. The Company’s technology offering aggregates data and applies analytics to make healthcare data transparent.